References
- Brinker AM, Ma J, Lipsky PE, Raskin I (2007): Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 68: 732–766.
- Cefalu WT, Ye J, Zuberi A, Ribnicky DM, Raskin I, Liu Z, Wang ZQ, Brantley PJ, Howard L, Lefevre M (2008): Botanicals and the metabolic syndrome. Am J Clin Nutr 87(2): 481S–487S.
- Lipsky PE, Tao XL, Cai J (1996): Preparations and uses thereof for immunosuppression. US Patent 5,580,562.
- Ma J, Dey M, Yang H, Poulev A, Pouleva R, Dorn R, Lipsky PE, Kennelly EJ, Raskin I (2007): Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry 68: 1172–1178.
- Raskin I, Ribnicky DM, Komarnytsky S, Ilic N, Poulev A, Borisjuk N, Brinker A, Moreno DA, Ripoll C, Yakoby N, O’Neal JM, Cornwell T, Pastor I, Fridlender B (2002): Plants and human health in the twenty-first century. Trends Biotechnol 20: 522–531.
- Ribnicky DM, Poulev A, Watford M, Cefalu WT, Raskin I (2006): Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L. Phytomedicine 13:550–557.
- Ribnicky DM, Kuhn P, Poulev A, Logendra S, Zuberi A, Cefalu WT, Raskin I (2009): Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L. Int J Pharm 370(1–2): 87–92.
- Tao X, Cush JJ, Garret M, Lipsky PE (2001): A phase I study of ethyl acetate extract of the Chinese antihreumatic herb Tripterygium wilfordii Hook.f. in rheumatoid arthritis. J Rheumatol 28: 2160–2167.
- Tao X, Younger J, Fan FZ, Wang B, Lipsky PE (2002): Benefit of an extract of Tripterygium wilfordii Hook.f. in patients with rheumatoid arthritis: A double-blind, placebo-controlled study. Arthritis Rheum 46: 1735–1743.
- Yao WC, Nian HF (2004): Medicated wine of Tripterygim wilfordii in treating rheumatoid arthritis in 392 patients. Zhongguo Xinyao yu Linchuan Zazhi 23: 35–37.